Arvaya Healthcare gets BSE in-principle approval for preferential issue

Arvaya Healthcare Ltd has received in-principle approval from the Bombay Stock Exchange (BSE) for a preferential issue of 38,71,854 equity shares. The shares will be issued at a price of ₹40 each, with a face value of ₹10 per share. This approval is a crucial step in the process, and the company must ensure strict compliance with SEBI regulations, including obtaining undertakings from allottees regarding intra-day trading restrictions. The BSE has reserved the right to withdraw this approval if any information provided is found to be incorrect or misleading.